Integra Lifesciences Holdings (IART) Gains from Investment Securities (2014 - 2026)
Integra Lifesciences Holdings' (IART) quarterly Gains from Investment Securities came in at $519000.0 in Q2 2026, up 1365.85% year-over-year from $35406.0 in Q2 2025, and up 140.14% quarter-over-quarter from -$1.3 million in Q1 2026.
Powered by 
Analysis
Integra Lifesciences Holdings (IART) Gains from Investment Securities (2014 - 2026) Analysis & Trends
Integra Lifesciences Holdings has disclosed Gains from Investment Securities across 13 years of filings, most recently posting $519000.0 for Q2 2026.
- In Q2 2026, Gains from Investment Securities rose 1365.85% year-over-year to $519000.0; the TTM figure through Jun 2026 stood at -$21.9 million (down 180.84% YoY), while the FY2025 annual figure was -$21.3 million, down 268.31% from the prior year.
- Gains from Investment Securities came in at $519000.0 for Q2 2026 at Integra Lifesciences Holdings, up from -$1.3 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $4.7 million in Q1 2023 to a low of -$14.4 million in Q3 2025.
- Average Gains from Investment Securities over 5 years is -$2.0 million, with a median of -$463500.0 recorded in 2022.
- Year-over-year, Gains from Investment Securities tumbled 8505.03% in 2022 and soared 1365.85% in 2026.
- Over 5 years, Gains from Investment Securities stood at -$823000.0 in 2022, then soared by 660.15% to $4.6 million in 2023, then slumped by 218.7% to -$5.5 million in 2024, then slipped by 22.17% to -$6.7 million in 2025, then jumped by 107.76% to $519000.0 in 2026.
- Per Business Quant data, the three most recent Gains from Investment Securities figures were $519000.0 in Q2 2026, -$1.3 million in Q1 2026, and -$6.7 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Integra Lifesciences Holdings | 1.25 Bn | 977.26 Mn | 219.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 519,000.00 |
| Mar 31, 2026 | -1.29 Mn |
| Dec 31, 2025 | -6.69 Mn |
| Sep 30, 2025 | -14.44 Mn |
| Jun 30, 2025 | -41,000.00 |
| Mar 31, 2025 | -162,000.00 |
| Dec 31, 2024 | -5.47 Mn |
| Sep 30, 2024 | -2.12 Mn |
| Jun 30, 2024 | 1.35 Mn |
| Mar 31, 2024 | 456,000.00 |
| Dec 31, 2023 | 4.61 Mn |
| Sep 30, 2023 | 2.20 Mn |
| Jun 30, 2023 | 1.38 Mn |
| Mar 31, 2023 | 4.70 Mn |
| Dec 31, 2022 | -823,000.00 |
| Sep 30, 2022 | -13.68 Mn |
| Jun 30, 2022 | -5.03 Mn |
| Mar 31, 2022 | -765,000.00 |
| Dec 31, 2021 | -1.62 Mn |
| Sep 30, 2021 | -159,000.00 |